DBAW:NYE-Xtrackers MSCI All World ex U.S. Hedged Equity ETF (USD)

ETF | Foreign Large Blend |

Last Closing

USD 34.91

Change

+0.01 (+0.03)%

Market Cap

N/A

Volume

7.29K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Foreign Large Blend

Symbol Name Price(Change) Market Cap
SCHF Schwab International Equity ET..

-0.25 (-0.61%)

USD 41.50B
SPDW SPDR S&P World ex US

-0.21 (-0.56%)

USD 22.09B
IDEV iShares Core MSCI Internationa..

-0.41 (-0.58%)

USD 15.11B
IQLT iShares MSCI Intl Quality Fact..

-0.26 (-0.63%)

USD 8.36B
DBEF Xtrackers MSCI EAFE Hedged Equ..

-0.14 (-0.33%)

USD 6.52B
INTF iShares Edge MSCI Multifactor ..

-0.17 (-0.54%)

USD 1.22B
QEFA SPDR® MSCI EAFE StrategicFact..

-0.46 (-0.57%)

USD 1.00B
HFXI IQ 50 Percent Hedged FTSE Inte..

-0.18 (-0.65%)

USD 0.81B
JHMD John Hancock Multifactor Devel..

-0.12 (-0.34%)

USD 0.75B
MFDX PIMCO RAFI Dynamic Multi-Facto..

-0.45 (-1.38%)

USD 0.28B

ETFs Containing DBAW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Foreign Large Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.56% 100% F 72% C
Dividend Return 0.80% 7% C- 13% F
Total Return 16.36% 100% F 68% D+
Trailing 12 Months  
Capital Gain 24.63% 86% B+ 62% D
Dividend Return 0.86% 7% C- 9% A-
Total Return 25.50% 45% F 56% F
Trailing 5 Years  
Capital Gain 29.20% 45% F 60% D-
Dividend Return 19.77% 89% A- 67% D+
Total Return 48.97% 79% B- 62% D
Average Annual (5 Year Horizon)  
Capital Gain 4.94% N/A N/A 55% F
Dividend Return 8.81% N/A N/A 59% D-
Total Return 3.87% N/A N/A 70% C-
Risk Return Profile  
Volatility (Standard Deviation) 13.79% N/A N/A 67% D+
Risk Adjusted Return 63.89% N/A N/A 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike